Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
QuintilesIMS
Citi
Deloitte
Chubb
Dow
Argus Health
Julphar
Baxter

Generated: May 26, 2018

DrugPatentWatch Database Preview

Vanda Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for VANDA PHARMS INC, and what generic alternatives to VANDA PHARMS INC drugs are available?

VANDA PHARMS INC has two approved drugs.

There are sixteen US patents protecting VANDA PHARMS INC drugs.

There are one hundred and thirty-seven patent family members on VANDA PHARMS INC drugs in thirty-one countries.

Summary for Vanda Pharms Inc
International Patents:137
US Patents:16
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Vanda Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vanda Pharms Inc FANAPT iloperidone TABLET;ORAL 022192-002 May 6, 2009 AB RX Yes No 9,074,254 ➤ Sign Up ➤ Sign Up
Vanda Pharms Inc FANAPT iloperidone TABLET;ORAL 022192-001 May 6, 2009 AB RX Yes Yes 8,652,776 ➤ Sign Up ➤ Sign Up
Vanda Pharms Inc FANAPT iloperidone TABLET;ORAL 022192-002 May 6, 2009 AB RX Yes No 8,999,638 ➤ Sign Up ➤ Sign Up
Vanda Pharms Inc HETLIOZ tasimelteon CAPSULE;ORAL 205677-001 Jan 31, 2014 RX Yes Yes 9,730,910 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Vanda Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vanda Pharms Inc FANAPT iloperidone TABLET;ORAL 022192-006 May 6, 2009 RE39198 ➤ Sign Up
Vanda Pharms Inc FANAPT iloperidone TABLET;ORAL 022192-001 May 6, 2009 RE39198 ➤ Sign Up
Vanda Pharms Inc FANAPT iloperidone TABLET;ORAL 022192-005 May 6, 2009 RE39198 ➤ Sign Up
Vanda Pharms Inc FANAPT iloperidone TABLET;ORAL 022192-002 May 6, 2009 RE39198 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for VANDA PHARMS INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, & 12 mg ➤ Subscribe 2013-05-06
➤ Subscribe Capsules 20 mg ➤ Subscribe 2018-01-31
➤ Subscribe Capsules 20 mg ➤ Subscribe 2018-01-31

Non-Orange Book US Patents for Vanda Pharms Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
2,017,087,122 ➤ Sign Up
5,981,571 Benzodioxa alkylene ethers as melatonergic agents ➤ Sign Up
8,785,492 Treatment of circadian rhythm disorders ➤ Sign Up
6,060,506 Benzopyran derivatives as melatonergic agents ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Army
Citi
Baxter
McKesson
Cipla
Fish and Richardson
Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.